Clinical trial
Reinforcement Learning and Obsessive-compulsive Disorder: Exploring the Role of the Orbitofrontal Cortex
NCT06566781 is registered in ClinicalTrials.gov with Fundacao Champalimaud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reinforcement Learning and Obsessive-compulsive Disorder: Exploring the Role of the Orbitofrontal Cortex
- Lead sponsor
- Fundacao Champalimaud
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 1, 2019
- Completion date
- December 31, 2026
- Enrollment
- 230 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.